Evaluation of ultrasmall superparamagnetic iron oxide-enhanced MRI of carotid atherosclerosis to assess risk of cerebrovascular and cardiovascular events: Follow-up of the ATHEROMA trial

Cerebrovascular Diseases

Volumn 34, Issue 2, 2012, Pages 169-173

  Degnan, Andrew J ^a   Patterson, Andrew J ^a   Tang, Tjun Y ^a   Howarth, Simon P S ^a   Gillard, Jonathan H ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; FOLLOW UP; HUMAN; LONG TERM CARE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL;

AGED; CAROTID ARTERY DISEASES; CONTRAST MEDIA; DEXTRANS; DIABETES COMPLICATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIER ESTIMATE; MACROPHAGE ACTIVATION; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PROPORTIONAL HAZARDS MODELS; PYRROLES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STROKE;

EID: 84865296057     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000339984     Document Type: Article

References (15)

1. Matijevic N, Wu KK, Howard AG, Wasserman B, Wang WY, Folsom AR, Sharrett AR: Association of blood monocyte and platelet markers with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI study. Cerebrovasc Dis 2011; 31: 552-558.
2. Katsargyris A, Tsiodras S, Theocharis S, Giaginis K, Vasileiou I, Bakoyiannis C, Georgopoulos S, Bastounis E, Klonaris C: Toll-like receptor immunohistochemical expression is enhanced in macrophages of symptomatic carotid atherosclerotic plaques. Cerebrovasc Dis 2011; 31: 29-36.
3. Bjornerud A, Johansson LO, Briley-Saebo K, Ahlstrom HK: Assessment of T 1 and T 2 effects in vivo and ex vivo using iron oxide nanoparticles in steady state-dependence on blood volume and water exchange. Magn Reson Med 2002; 47: 461-471.
4. Schmitz SA, Taupitz M, Wagner S, Wolf KJ, Beyersdorff D, Hamm B: Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging 2001; 14: 355-361.
5. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM: Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003; 107: 2453-2458.
6. Trivedi RA, U-King-Im JM, Graves MJ, Cross JJ, Horsley J, Goddard MJ, Skepper JN, Quartey G, Warburton E, Joubert I, Wang L, Kirkpatrick PJ, Brown J, Gillard JH: In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004; 35: 1631-1635.
7. Howarth S, Li ZY, Trivedi RA, U-King-Im JM, Graves MJ, Kirkpatrick PJ, Gillard JH: Correlation of macrophage location and plaque stress distribution using USPIO-enhanced MRI in a patient with symptomatic severe carotid stenosis: a new insight into risk stratification. Br J Neurosurg 2007; 21: 396-398.
8. Tang T, Howarth SP, Miller SR, Trivedi R, Graves MJ, U-King-Im JM, Li ZY, Brown AP, Kirkpatrick PJ, Gaunt ME, Gillard JH: Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxideenhanced MRI. Stroke 2006; 37: 2266-2270.
9. Howarth SP, Tang TY, Trivedi R, Weerakkody R, U-King-Im JM, Gaunt ME, Boyle JR, Li ZY, Miller SR, Graves MJ, Gillard JH: Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals. Eur J Radiol 2009; 70: 555-560.
10. Tang TY, Howarth SP, Miller SR, Graves MJ, Patterson AJ, U-King-Im JM, Li ZY, Walsh SR, Brown AP, Kirkpatrick PJ, Warburton EA, Hayes PD, Varty K, Boyle JR, Gaunt ME, Zalewski A, Gillard JH: The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 2009; 53: 2039-2050.
11. Nicolaides AN: Asymptomatic carotid stenosis and risk of stroke. Identification of a high risk group (ACSRS). A natural history study. Int Angiol 1995; 14: 21-23.
12. Altaf N, Daniels L, Morgan PS, Auer D, MacSweeney ST, Moody AR, Gladman JR: Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. J Vasc Surg 2008; 47: 337-342.
13. Lombardo A, Biasucci LM, Lanza GA, Coli S, Silvestri P, Cianflone D, Liuzzo G, Burzotta F, Crea F, Maseri A: Inflammation as a possible link between coronary and carotid plaque instability. Circulation 2004; 109: 3158-3163.
14. Papini GD, Di Leo G, Tritella S, Nano G, Cotticelli B, Clemente C, Tealdi DG, Sardanelli F: Evaluation of inflammatory status of atherosclerotic carotid plaque before thromboendarterectomy using delayed contrast-enhanced subtracted images after magnetic resonance angiography. Eur J Radiol 2011
15. Papini GD, Cotticelli B, Tritella S, Clemente C, Di Leo G, Tealdi D, Sardanelli F: Carotid plaque contrast enhancement (CPCE) at magnetic resonance (MR) imaging: association with inflammatory cell infiltration (ICI) or cerebro-or cardio-vascular events (CCVE). Radiological Society of North America, Chicago, 2010.